Search This Blog

Monday, February 3, 2020

Taro Pharmaceutical EPS beats by $0.22, misses on revenue

Taro Pharmaceutical (NYSE:TARO): Q3 GAAP EPS of $1.76 beats by $0.22.
Revenue of $147.68M (-8.2% Y/Y) misses by $24.33M.
Press Release
https://seekingalpha.com/news/3537673-taro-pharmaceutical-eps-beats-0_22-misses-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)